Catherine Merity has wide-ranging experience in corporate law and has practised in both Australia and the UK. In particular, she is acknowledged for her experience in equity capital markets transactions and has acted in a large number of multi-jurisdictional matters in this field. This includes advising Australian and international clients on initial public offerings (IPOs), capital raisings, schemes of arrangement, private acquisitions and disposals, public takeovers, joint ventures, ASX Listing Rules, Corporations Act 2001 (Cth) compliance, as well as corporate governance.

Catherine acts for clients from a range of industry sectors, with an increasing focus on the life sciences sector. She played a lead role in assisting two ASX-listed medical device companies with re-domiciliation to the United States and dual listing on NASDAQ, and has since advised on subsequent capital raisings by these companies across both markets. Catherine also acted as issuer counsel on the noteworthy IPOs of US life sciences companies, REVA Medical, Inc. and GI Dynamics, Inc.